Evidence map›Paper›PMID 29854877›Full record

ArticleOncoscience2018

A novel isolation method for cancer prognostic factors via the p53 pathway by a combination of

Yohey Kamijo, Kohichi Kawahara, Takuma Yoshinaga, Hiroyuki Kurata, Kazunari Arima, Tatsuhiko Furukawa

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yohey Kamijo *Department of Molecular Oncology, Graduate School Medical and Dental Sciences, Kagoshima University, Kagoshima 890- 8544, Japan.
Kohichi Kawahara *Department of Molecular Oncology, Graduate School Medical and Dental Sciences, Kagoshima University, Kagoshima 890- 8544, Japan.
Takuma YoshinagaDivision of Clinical Application, Nanpuh Hospital, Kagoshima 892-8512, Japan.
Hiroyuki KurataDepartment of Bioscience and Bioinformatics, Kyushu Institute of Technology, Fukuoka 820-8502, Japan.
Kazunari ArimaDepartment of Chemistry and Bioscience, Faculty of Science, Graduate School of Science and Engineering, Kagoshima University, Kagoshima 890-0065, Japan.
Tatsuhiko FurukawaDepartment of Molecular Oncology, Graduate School Medical and Dental Sciences, Kagoshima University, Kagoshima 890- 8544, Japan.
Kagoshima University · JPKyushu Institute of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identifying new therapeutic target genes affecting the survival of patients with cancer is crucial for the development of new cancer therapies. Here, we developed a novel technology combining

Indexed as

cancergenome analysisp53short-hairpin RNAtumor-suppressor pathway

Identifiers

PMID29854877
PMCPMC5978436
OpenAlexW2982004882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.